Description
Multi-Receptor Metabolic Peptide Blend for Research
Technical Overview
This co-formulated blend pairs Retatrutide, a synthetic peptide studied as a triple agonist across the GIP, GLP-1, and glucagon receptor families, with Cagrilintide, a long-acting amylin analogue. In laboratory environments the combination is investigated for overlapping incretin and amylin signaling pathways. Both peptides are produced by solid-phase peptide synthesis and purified by HPLC to analytical standards.
Specifications
Purity: ≥ 99% (HPLC Verified)
Ratio: 12.5 mg / 2.5 mg
Appearance: Lyophilized Powder
Format: Research Compound
Storage: Store at −20°C.
Research Disclaimer
Provided strictly as a chemical reagent for laboratory investigation. Not for human or veterinary use of any kind.
Reviews
There are no reviews yet.